Kaempferol Attenuates Cardiac Hypertrophy via Regulation of ASK1/MAPK Signaling Pathway and Oxidative Stress

Planta Medica

Volumn 83, Issue 10, 2017, Pages 837-845

  Feng, Hong ^a   Cao, Jianlei ^a   Zhang, Guangyu ^a   Wang, Yanggan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

ASK1; cardiac hypertrophy; kaempferol; MAPK; oxidative stress

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; KAEMPFEROL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; KAEMPFEROL DERIVATIVE; MAP3K5 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; CYTOLYSIS; DESCENDING AORTA; ECHOCARDIOGRAPHY; ENZYME PHOSPHORYLATION; HEART CYCLE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART TISSUE; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CARDIOMEGALY; CELL CULTURE; DRUG EFFECTS; FIBROSIS; MAPK SIGNALING; METABOLISM;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; FIBROSIS; KAEMPFEROLS; MALE; MAP KINASE KINASE KINASE 5; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 85013477865     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0043-103415     Document Type: Article

References (34)

1. Ziaeian B. Fonarow G. C. Epidemiology and aetiology of heart failure. Nat Rev Cardiol: 2016; 13 368 378
2. Ezekowitz J. A. Kaul P. Bakal J. A. Quan H. McAlister F. A. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail: 2011; 13 142 147
3. Schiattarella G. G. Hill J. A. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation: 2015; 131 1435 1447
4. Rose B. A. Force T. Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev: 2010; 90 1507 1546
5. Ravingerova T. Barancik M. Strniskova M. Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol Cell Biochem: 2003; 247 127 138
6. Calderon-Montano J. M. Burgos-Moron E. Perez-Guerrero C. Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem: 2011; 11 298 344
7. Lin J. Rexrode K. M. Hu F. Albert C. M. Chae C. U. Rimm E. B. Stampfer M. J. Manson J. E. Dietary intakes of flavonols and flavones and coronary heart disease in us women. Am J Epidemiol: 2007; 165 1305 1313
8. Zhou M. Ren H. Han J. Wang W. Zheng Q. Wang D. Protective effects of kaempferol against myocardial ischemia/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3beta. Oxid Med Cell Longev: 2015; 2015 481405
9. Suchal K. Malik S. Gamad N. Malhotra R. K. Goyal S. N. Chaudhary U. Bhatia J. Ojha S. Arya D. S. Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury. Oxid Med Cell Longev: 2016; 2016 7580731
10. Klawitter J. Agardi E. Corby K. Leibfritz D. Lowes B. D. Christians U. Seres T. Association of dj-1/pten/akt- and ask1/p38-mediated cell signalling with ischaemic cardiomyopathy. Cardiovasc Res: 2013; 97 66 76
11. Bell R. M. Botker H. E. Carr R. D. Davidson S. M. Downey J. M. Dutka D. P. Heusch G. Ibanez B. Macallister R. Stoppe C. Ovize M. Redington A. Walker J. M. Yellon D. M. 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection. Basic Res Cardiol: 2016; 111 41
12. Liu Q. Sargent M. A. York A. J. Molkentin J. D. Ask1 regulates cardiomyocyte death but not hypertrophy in transgenic mice. Circ Res: 2009; 105 1110 1117
13. Zhang Y. Liu Y. Zhu X. H. Zhang X. D. Jiang D. S. Bian Z. Y. Zhang X. F. Chen K. Wei X. Gao L. Zhu L. H. Yang Q. Fan G. C. Lau W. B. Ma X. Li H. Dickkopf-3 attenuates pressure overload-induced cardiac remodelling. Cardiovasc Res: 2014; 102 35 45
14. Yamaguchi O. Higuchi Y. Hirotani S. Kashiwase K. Nakayama H. Hikoso S. Takeda T. Watanabe T. Asahi M. Taniike M. Matsumura Y. Tsujimoto I. Hongo K. Kusakari Y. Kurihara S. Nishida K. Ichijo H. Hori M. Otsu K. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci U S A: 2003; 100 15883 15888
15. Nakamura T. Kataoka K. Fukuda M. Nako H. Tokutomi Y. Dong Y. F. Ichijo H. Ogawa H. Kim-Mitsuyama S. Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis. Hypertension: 2009; 54 544 551
16. Hikoso S. Ikeda Y. Yamaguchi O. Takeda T. Higuchi Y. Hirotani S. Kashiwase K. Yamada M. Asahi M. Matsumura Y. Nishida K. Matsuzaki M. Hori M. Otsu K. Progression of heart failure was suppressed by inhibition of apoptosis signal-regulating kinase 1 via transcoronary gene transfer. J Am Coll Cardiol: 2007; 50 453 462
17. Bondonno C. P. Croft K. D. Ward N. Considine M. J. Hodgson J. M. Dietary flavonoids and nitrate: effects on nitric oxide and vascular function. Nutr Rev: 2015; 73 216 235
18. Wray D. W. Amann M. Richardson R. S. Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction. Heart Fail Rev: 2016; 10.1007/s10741-016-9573-4
19. Tham Y. K. Bernardo B. C. Ooi J. Y. Weeks K. L. McMullen J. R. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol: 2015; 89 1401 1438
20. Huang Q. Zhou H. J. Zhang H. Huang Y. Hinojosa-Kirschenbaum F. Fan P. Yao L. Belardinelli L. Tellides G. Giordano F. J. Budas G. R. Min W. Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function. Circulation: 2015; 131 1082 1097
21. Lu J. Holmgren A. Thioredoxin system in cell death progression. Antioxid Redox Signal: 2012; 17 1738 1747
22. Jain A. K. Mehra N. K. Swarnakar N. K. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des: 2015; 21 4441 4455
23. Travers J. G. Kamal F. A. Robbins J. Yutzey K. E. Blaxall B. C. Cardiac Fibrosis: The Fibroblast Awakens. Circ Res: 2016; 118 1021 1040
24. Lighthouse J. K. Small E. M. Transcriptional control of cardiac fibroblast plasticity. J Mol Cell Cardiol: 2016; 91 52 60
25. Hill K. S. Erdogan E. Khoor A. Walsh M. P. Leitges M. Murray N. R. Fields A. P. Protein kinase C α suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGF β signaling axis. Oncogene: 2014; 33 2134 2144
26. Watkins S. J. Jonker L. Arthur H. M. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy. Cardiovasc Res: 2006; 69 432 439
27. Chen Z. Zheng S. Li L. Jiang H. Metabolism of flavonoids in human: A comprehensive review. Curr Drug Metab: 2014; 15 48 61
28. Zheng L. Zhu L. Zhao M. Shi J. Li Y. Yu J. Jiang H. Wu J. Tong Y. Liu Y. Hu M. Lu L. Liu Z. In Vivo Exposure of Kaempferol is Driven by Phase II Metabolic Enzymes and Efflux Transporters. AAPS J: 2016; 18 1289 1299
29. DuPont M. S. Day A. J. Bennett R. N. Mellon F. A. Kroon P. A. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr: 2004; 58 947 954
30. Hertog M. G. Feskens E. J. Hollman P. C. Katan M. B. Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet: 1993; 342 1007 1011
31. Geleijnse J. M. Launer L. J. Van der Kuip D. A. Hofman A. Witteman J. C. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr: 2002; 75 880 886
32. Al-Numair K. S. Veeramani C. Alsaif M. A. Chandramohan G. Influence of kaempferol, a flavonoid compound, on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharm Biol: 2015; 53 1372 1378
33. Hoang M. H. Jia Y. Mok B. Jun H. J. Hwang K. Y. Lee S. J. Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver x receptor-beta. J Nutr Biochem: 2015; 26 868 875
34. Marano G. Ferrari A. U. Surgical animal model of ventricular hypertrophy. Methods Mol Med: 2007; 139 95 104